About sera prognostics inc - SERA
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
SERA At a Glance
Sera Prognostics, Inc.
2749 East Parleys Way
Salt Lake City, Utah 84109
| Phone | 1-801-990-0520 | Revenue | 81.00K | |
| Industry | Medical/Nursing Services | Net Income | -31,928,000.00 | |
| Sector | Health Services | 2025 Sales Growth | 5.195% | |
| Fiscal Year-end | 12 / 2026 | Employees | 72 | |
| View SEC Filings |
SERA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1,735.841 |
| Price to Book Ratio | 1.524 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -2.917 |
| Enterprise Value to Sales | 1,280.755 |
| Total Debt to Enterprise Value | 0.023 |
SERA Efficiency
| Revenue/Employee | 1,125.00 |
| Income Per Employee | -443,444.444 |
| Receivables Turnover | 6.75 |
| Total Asset Turnover | 0.001 |
SERA Liquidity
| Current Ratio | 1.686 |
| Quick Ratio | 1.686 |
| Cash Ratio | 1.621 |
SERA Profitability
| Gross Margin | -1,119.753 |
| Operating Margin | -45,066.667 |
| Pretax Margin | -39,417.284 |
| Net Margin | -39,417.284 |
| Return on Assets | -36.426 |
| Return on Equity | -51.827 |
| Return on Total Capital | -41.067 |
| Return on Invested Capital | -50.861 |
SERA Capital Structure
| Total Debt to Total Equity | 3.102 |
| Total Debt to Total Capital | 3.008 |
| Total Debt to Total Assets | 2.281 |
| Long-Term Debt to Equity | 3.099 |
| Long-Term Debt to Total Capital | 3.006 |